Clinical Trials Directory

Trials / Completed

CompletedNCT01708473

Feasibility Study: Compare the Effectiveness Between Two Pain Medications When Used Prior to Ultherapy™ Treatments

Feasibility Study: Comparison Of Advil® Vs. Lortab® For Reducing Discomfort Associated With Ultherapy™ Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Ulthera, Inc · Industry
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study will compare the effectiveness of two pain medications for reducing discomfort during an Ultherapy treatment.

Detailed description

This trial is a prospective, single-site, double-blinded, randomized trial. All study subjects will receive a full face and neck Ultherapy treatment. Subjects will be randomized to receive one of two pain medications prior to treatment. Each subject will be asked to rate the level of discomfort during the Ultherapy treatment. All study subjects will be followed for 90 days following treatment.

Conditions

Interventions

TypeNameDescription
DRUGAdvilOne (1) tablet 800 mg Advil one hour prior to treatment.
DRUGLortabOne (1) tablet 10/500 mg of Lortab one hour prior to treatment.
DEVICEUlthera System TreatmentFocused ultrasound energy delivered below the surface of the skin

Timeline

Start date
2011-07-01
Primary completion
2012-02-01
Completion
2012-02-01
First posted
2012-10-17
Last updated
2017-11-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01708473. Inclusion in this directory is not an endorsement.

Feasibility Study: Compare the Effectiveness Between Two Pain Medications When Used Prior to Ultherapy™ Treatments (NCT01708473) · Clinical Trials Directory